A carregar...
Low dose of apatinib in treating chemotherapy and EGFR-TKI refractory non-small cell lung cancer: A case report
RATIONALE: Lung cancer is the leading cause of cancer-associated deaths all over the world. Although the prognosis of lung cancer has improved over the past decade due to progression in surgical techniques and systematic treatments, the patients with advanced disease still suffer poor survival. Ther...
Na minha lista:
| Publicado no: | Medicine (Baltimore) |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Wolters Kluwer Health
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6380768/ https://ncbi.nlm.nih.gov/pubmed/30702616 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000014328 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|